Silence Therapeutics plc Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Silence Therapeutics plc stock issued during period, value, new issues for the quarter ending 2026-06-30 was $2.00K, a 100.00% increase year-over-year.
- Silence Therapeutics plc stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.00K, a 99.92% decline year-over-year.
- Silence Therapeutics plc stock issued during period, value, new issues for the quarter ending 2025-03-31 was $14.00K, a 99.99% decline year-over-year.
- Silence Therapeutics plc stock issued during period, value, new issues for the quarter ending 2024-09-30 was $7.97M.
- Silence Therapeutics plc stock issued during period, value, new issues for fiscal 2025 was $15.00K, a 99.99% decline from fiscal 2024.
- Silence Therapeutics plc stock issued during period, value, new issues for fiscal 2024 was $142.09M, a 344.90% increase from fiscal 2023.
- Silence Therapeutics plc stock issued during period, value, new issues for fiscal 2023 was $31.94M, a 39.26% decline from fiscal 2022.
- Silence Therapeutics plc stock issued during period, value, new issues for fiscal 2022 was $52.58M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $15.00K 10-K · filed 2026-03-05 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $14.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $142.09M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $7.97M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.19M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $133.02M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $31.94M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $52.58M 10-K · filed 2025-02-27 |